ProteoNic Biotechnology licenses Protein Production technology to Eli Lilly and Company

Leiden, the Netherlands, Feb 5, 2019.  ProteoNic Biotechnology BV announces that it licensed its 2G UNic™technology for boosting recombinant protein production to Eli Lilly and Company.

Under the agreement, Lilly gains non-exclusive commercial rights for application of the technology to the development of proprietary products. Financial details of the agreement were…